Feng Li
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- RNA modifications and cancer
- Protein Kinase Regulation and GTPase Signaling
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 20
- RNA modifications and cancer 20
- Cancer-related gene regulation 16
- Epigenetics and DNA Methylation 13
-
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 22
- Co-authors
- Chi V. Dang (2 shared papers)Tam Nguyen (1 shared paper)Karen Zeller (1 shared paper)Kathryn A. O’Donnell (1 shared paper)Xiaodong Li (4 shared papers)Hongdan Li (2 shared papers)Rakesh Kumar (5 shared papers)Yangguang Shao (8 shared papers)
- Journals
- Oncogene (7 papers)Oncotarget (7 papers)International Journal of Biological Macromolecules (5 papers)Cell Death and Disease (4 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Feng Li
227 papers receiving 7.6k citations
Feng Li's Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 1.7k
- Molecular Biology 4.7k
- Oncology 1.6k
- Cell Biology 602
- Geriatrics and Gerontology 108
Countries citing papers authored by Feng Li
This map shows the geographic impact of Feng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Li more than expected).
Fields of papers citing papers by Feng Li
This network shows the impact of papers produced by Feng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Li. The network helps show where Feng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The c-Myc target gene network Hit paper breakdown → | 2006 | 937 |
| 2 | HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo Hit paper breakdown → | 2007 | 432 |
| 3 | 1998 | 183 | |
| 4 | 2016 | 172 | |
| 5 | 2008 | 170 | |
| 6 | 2006 | 170 | |
| 7 | 2013 | 128 | |
| 8 | 2011 | 124 | |
| 9 | 2004 | 119 | |
| 10 | 2011 | 115 | |
| 11 | 2009 | 106 | |
| 12 | 2014 | 95 | |
| 13 | 2016 | 92 | |
| 14 | 2018 | 89 | |
| 15 | 2011 | 86 | |
| 16 | 2018 | 83 | |
| 17 | 2021 | 80 | |
| 18 | 2003 | 79 | |
| 19 | 2016 | 77 | |
| 20 | 2017 | 73 |
About Feng Li
Feng Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 237 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (22 papers), Cancer-related Molecular Pathways (20 papers), Protein Kinase Regulation and GTPase Signaling (20 papers), RNA modifications and cancer (20 papers), Cancer-related gene regulation (16 papers), Epigenetics and DNA Methylation (13 papers) and Ferroptosis and cancer prognosis (11 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (4.7k citations), Oncology (1.6k citations), Cell Biology (602 citations) and Geriatrics and Gerontology (108 citations). Feng Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Chi V. Dang, Tam Nguyen, Karen Zeller, Kathryn A. O’Donnell, Xiaodong Li, Hongdan Li, Rakesh Kumar, Yangguang Shao, Ratna K. Vadlamudi and Maosheng Cheng. Their work appears in journals such as Oncogene, Oncotarget, International Journal of Biological Macromolecules, Cell Death and Disease and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.